Evidence map›Paper›PMID 37914994›Full record

ArticleBMC cancer2023

The analysis of HPV integration sites based on nanopore sequencing and the profiling changes along the course of photodynamic therapy.

Xiulan Li, Xiaoke Wei, Xin Liu, Nan Wang, Fuqiang Xu, Xingyu Liu, Yanmei Li, Yuxiang Zhou, Huadong Tang, Meina Bian and 4 more

Open access · goldAbstract read
In one paragraph

Article in BMC cancer, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.8field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 5 citations in OpenAlex.

  1. Case Report: Possible spatially-distinctFrontiers in medicine · 2026
    Article
  2. Article
  3. Article
  4. Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 2 countries.

Xiulan Li *Department of Gynecology, Beijing Youan Hospital, Capital Medical University, Beijing, 100069, China.
Xiaoke Wei *Geneis, Bldg A, 5 Guangshun North Street, Beijing, 100102, China.
Xin LiuDepartment of Gynecology, Beijing Youan Hospital, Capital Medical University, Beijing, 100069, China.
Nan WangDepartment of Gynecology, Beijing Youan Hospital, Capital Medical University, Beijing, 100069, China.
Fuqiang XuDepartment of Gynecology, Beijing Youan Hospital, Capital Medical University, Beijing, 100069, China.
Xingyu LiuGeneis, Bldg A, 5 Guangshun North Street, Beijing, 100102, China.
Yanmei LiDepartment of Gynecology, Beijing Youan Hospital, Capital Medical University, Beijing, 100069, China.
Yuxiang ZhouDepartment of Gynecology, Beijing Youan Hospital, Capital Medical University, Beijing, 100069, China.
Huadong TangDepartment of Gynecology, Beijing Youan Hospital, Capital Medical University, Beijing, 100069, China.
Meina BianDepartment of Gynecology, Beijing Youan Hospital, Capital Medical University, Beijing, 100069, China.
Ying HouDepartment of Gynecology, Beijing Youan Hospital, Capital Medical University, Beijing, 100069, China.
Lili ZhangGeneis, Bldg A, 5 Guangshun North Street, Beijing, 100102, China. zhangll@geneis.cn.
Weiwei WangGeneis, Bldg A, 5 Guangshun North Street, Beijing, 100102, China. wangww@geneis.cn.
Qing LiuDepartment of Gynecology, Beijing Youan Hospital, Capital Medical University, Beijing, 100069, China. xiaochu34@163.com.
Beijing YouAn Hospital · CNCapital Medical University · CNGenesys (United States) · USShanghai Genon Biological Products (China) · CN

Funding

Talent Training Program of Beijing Hospitals Authority DFL20191701the Beijing Health Technologies Promotion Program BHTPP2020
6 · The paper itself

Abstract

objectiveTo detect the HPV genotype and integration sites in patients with high-risk HPV infection at different stages of photodynamic therapy using nanopore technology and to evaluate the treatment effect.

methodsFour patients with HPV infection were selected and subjected to photodynamic therapy, and cervical exfoliated cell was sampled at before treatment, after three courses of treatment and six courses of treatment, their viral abundance and insertion sites were analyzed by nanopore technology, and pathological examinations were performed before and after treatment. In this study, we developed a novel assay that combined viral sequence enrichment and Nanopore sequencing for identification of HPV genotype and integration sites at once. The assay has obvious advantages over qPCR or NGS-based methods, as it has better sensitivity after viral sequences enrichment and can generate long-reads (kb to Mb) for better detection rate of structure variations, moreover, fast turn-around time for real-time viral sequencing and analysis.

resultsThe pathological grade was reduced in all four patients after photodynamic therapy. Virus has been cleared in two cases after treatment, the virus amount reduced after treatment but not completely cleared in one case, and two type viruses were cleared and one type virus persisted after treatment in the last patient with multiple infection. Viral abundance and the number of integration sites were positively correlated. Gene enrichment analysis showed complete viral clearance in 1 patient and 3 patients required follow-up.

conclusionNanopore sequencing can effectively monitor the abundance of HPV viruses and integration sites to show the presence status of viruses, and combined with the results of gene enrichment analysis, the treatment effect can be dynamically assessed.

Indexed as

Nanopore SequencingPapillomavirus InfectionsPhotochemotherapyUterine Cervical NeoplasmsDNA, ViralFemaleHumansVirus IntegrationDNA, ViralCervical carcinomasHuman papillomavirusNanopore sequencingPhotodynamic therapy

Identifiers

PMID37914994
PMCPMC10621124
OpenAlexW4388229389

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.